[Clinical study of male urethritis in Oogaki Municipal Hospital].
We studied 181 patients diagnosed with male urethritis at Oogaki Municipal Hospital from April 2002 to March 2004. Twenty-two out of 92 patients diagnosed with gonococcal urethritis (GU) and 52 out of 89 patients diagnosed with non-gonococcal urethritis (NGU) were positive for Chlamidia trichomatis by polymerase chain reaction (PCR). Most patients of male urethritis were in their twenties. Of GU patients, 39 (67%) were infected from commercial sex workers (CSWs). Of NGU patients, 12 (30%) were infected from CSWs, 24 (40%) from girl friends and 4 (10%) from their Twenty-eight (48%) out of GU patients were infected through oral sex. spouse. Eighty-three GU patients were treated with SPCM (2 g, one shot). Fifty-five patients could be evaluated for the efficacy of treatment. Elimination rate of Neisseria gonorrhoeae was 100% and 14 out of 18 patients with persisting urethritis had C. trichomatis. Eighty-two NGU patients were treated with minocycline, tosufloxacin, levofloxacin, gatiflixacin or clarithromycine. Sixty-six patients could be evaluated for the efficacy of treatment. Forty-one patients were diagnosed with non-gonococcal chlamydial urethritis (NGCU) and 25 patients were diagnosed with non-gonococcal, non-chlamydial urethritis (NGNCU). The clinical curative rate of NGCU and NGNCU was 93% (38/41) and 80% (20/25), respectively.
Komeda
Hisao
H
The Department of Urology, Oogaki Municipal Hospital.
Fujimoto
Yoshinori
Y
Uno
Masahiro
M
Takada
Toshihiko
T
Yamada
Yoshiteru
Y
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002690:Chlamydia Infections / Q000188:drug therapy / Q000453:epidemiology; D024841:Fluoroquinolones / Q000627:therapeutic use; D006069:Gonorrhea / Q000188:drug therapy / Q000453:epidemiology; D006773:Hospitals, Municipal; D006801:Humans; D007564:Japan / Q000453:epidemiology; D064704:Levofloxacin; D008297:Male; D008875:Middle Aged; D008911:Minocycline / Q000627:therapeutic use; D009287:Naphthyridines / Q000627:therapeutic use; D015242:Ofloxacin / Q000627:therapeutic use; D012747:Sexual Partners; D015231:Sexually Transmitted Diseases, Bacterial / Q000188:drug therapy* / Q000453:epidemiology*; D000198:Spectinomycin / Q000627:therapeutic use*; D014526:Urethritis / Q000188:drug therapy* / Q000453:epidemiology*
D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D009287:Naphthyridines; D064704:Levofloxacin; D000198:Spectinomycin; D015242:Ofloxacin; D008911:Minocycline; C055185:tosufloxacin